title: Pfizer versus Kaiser: insurers want their day in court.
authors.affiliation: Pharmalot, Millburn, NJ, USA. pharmalot@gmail.com
authors.forename: Ed
authors.initials: E
authors.lastname: Silverman
mesh_terms: D000588:Amines / Q000191:economics; D000927:Anticonvulsants / Q000191:economics; D003509:Cyclohexanecarboxylic Acids / Q000191:economics; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D000077206:Gabapentin; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000191:economics / Q000331:legislation & jurisprudence*; D040541:Marketing / Q000331:legislation & jurisprudence*; D056687:Off-Label Use / Q000191:economics / Q000331:legislation & jurisprudence*; D010818:Practice Patterns, Physicians'; D014481:United States; D005680:gamma-Aminobutyric Acid / Q000191:economics
chemical_list: D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin